The Effect of an Aromatherapy Intervention on Sleep in the ICU
What is the Effect of an Aromatherapy Intervention on Sleep in the ICU? An Exploratory Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, SW3 6JJ
- The Royal Marsden NHS Foundation Trust
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- any NHS patient with cancer admitted to the CCU during the period of the study
- aged 18 years or over
- who wishes to take part in the study
Exclusion Criteria:
- expected length of stay < 4 days
- habitual use of sleep medication more than 3 times per week
- no sleep meds/hypnotics allowed during study period
- no sedation during intervention period (propofol; clonidine; midazolam)
- extensive brain metastases/hypoxic or traumatic brain injury
- sleep apnoea
- excessive alcohol consumption >50 units/week (ascertained via notes)
- extensive wound/skin damage that precludes massage (e.g. drug-related bullae/skin desquamation)
- neuromuscular blockade
- any normal massage contraindications including: severe respiratory or hemodynamic instability, GCS <7*, ICP <20* mmHg, no contraindication for changing in body position (including active significant bleeding etc)
- allergies to the use of essential oils, either on the skin or inhaled, precluding the use of both of the study blends
- allergy to base (grapeseed) oil
Study Plan
How is the study designed?
Design Details
- Primary Purpose: SUPPORTIVE_CARE
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: Aroma group
|
|
|
NO_INTERVENTION: Control Group
Normal Care
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
• Differences in RCSQ patient scores
Time Frame: 24 months
|
24 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
• Difference in BIS scores
Time Frame: 24 months
|
24 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- CCR 4308
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.